Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer

BACKGROUND: ER+HER2+ breast cancer requires most types of systemic therapies perioperatively. However, treatment resistance is often experienced. The current study investigated the predictive and prognostic value of intratumoral heterogeneity and conventional clinicopathological factors in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Teruya, Natsuki, Inoue, Hiroaki, Horii, Rie, Akiyama, Futoshi, Ueno, Takayuki, Ohno, Shinji, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225233/
https://www.ncbi.nlm.nih.gov/pubmed/36934442
http://dx.doi.org/10.1002/cam4.5788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225233/
https://www.ncbi.nlm.nih.gov/pubmed/36934442
http://dx.doi.org/10.1002/cam4.5788

Ejemplares similares